Search
MenABCWY QUINTET Study Meningococcal disease is a rare but serious disease that can result in death if not recognised and treated quickly. There are
Coming up in 2021 We have a a study to suit every age range in 2021! From babies at just six weeks for the FluBub Study, through to teenagers in
COVID-19 Research Update
Latest news & events at the Wesfarmers Centre of Vaccines & Infectious Diseases.
IIC Perth 2019 Faculty Testimonials Contact us I liked the breadth available in the course: both local and international, and very specialised areas
News & Events
Respiratory SymposiumMore information For more information regarding the Respiratory Symposium, please contact Dr Hannah Moore.
Find out more about the scholarship opportunities at the Wesfarmers Centre, including Training Scholarships and Higher Degree by Research Scholarships.
Wesfarmers Centre of Vaccines & Infectious Diseases resources
Research
Modelling Micro-Elimination: Third-Trimester Tenofovir Prophylaxis for Perinatal Transmission of Hepatitis B in the Remote Dolpa District of NepalHepatitis B (HBV) prevalence is very high in pregnant women in the Dolpa district of Nepal, a region characterised by a remote geographic landscape and low vaccination coverage. Using mathematical modelling, we evaluated the impact of third-trimester tenofovir disoproxil fumarate (TDF) prophylaxis on HBV burden and estimated the time required to achieve HBV elimination in Dolpa.
Research
Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS)The in-vivo plasma concentration of penicillin needed to prevent Streptococcus pyogenes pharyngitis, recurrent acute rheumatic fever, and progressive rheumatic heart disease is not known. We used a human challenge model to assess the minimum penicillin concentration required to prevent streptococcal pharyngitis.